GATA6 loss-of-function mutations contribute to familial dilated cardiomyopathy

Area of Science:

• Cardiovascular Genetics
• Molecular Cardiology
• Genetic Basis of Heart Disease

Background:

• Dilated cardiomyopathy (DCM) is a primary heart muscle disease and a leading cause of heart failure and cardiac transplantation.
• Genetic factors play a significant role in DCM pathogenesis, yet its genetic basis remains largely unknown due to heterogeneity.
• GATA6, a transcription factor crucial for heart development, is implicated in cardiogenesis.

Purpose of the Study:

• To investigate the role of GATA6 gene mutations in the development of familial dilated cardiomyopathy.
• To identify novel mutations in GATA6 associated with DCM and analyze their inheritance patterns and functional consequences.

Main Methods:

• Sequencing of the GATA6 gene in 140 unrelated DCM patients.
• Segregation analysis in affected families to confirm co-inheritance of mutations with DCM.
• In silico prediction of pathogenicity (MutationTaster, PolyPhen-2) and cross-species protein alignment.
• Functional assays to assess the impact of mutations on GATA6 transcriptional activity.

Main Results:

• Two novel heterozygous GATA6 mutations (p.C447Y and p.H475R) were identified in DCM patients.
• These mutations co-segregated with DCM in an autosomal-dominant pattern with complete penetrance.
• Mutated GATA6 proteins exhibited significantly reduced transcriptional activation compared to wild-type, indicating loss-of-function.

Conclusions:

• Loss-of-function mutations in GATA6 are associated with an increased susceptibility to familial dilated cardiomyopathy.
• This finding provides new insights into the molecular mechanisms underlying DCM.
• Potential implications for antenatal prophylaxis and allele-specific treatments for DCM patients carrying GATA6 mutations.